• VA2 Correlates of Protection for Vaccines- When Does a Correlate Equal Protection?

    Nov 1, 2012, 00:00

  • PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PSY43 Utilization of Pain Medications in Patients With Chronic Lower Back Pain Who Initiated Duloxetine or Standard of Care for the Management of Pain

    Nov 1, 2012, 00:00

  • NI2 The Use of Off-Label Comparators in Nice Appraisals – An Indirect Endorsement?

    Nov 1, 2012, 00:00

  • PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

    Nov 1, 2012, 00:00

  • PRM109 Content Validity of a Treatment Satisfaction Questionnaire in Non-Hodgkin's Lymphoma

    Nov 1, 2012, 00:00

  • PSY4 Studies on Lead Detoxifying Effect of Ascorbic Acid in Traffic Police Subjects of Karachi

    Nov 1, 2012, 00:00

  • PRM124 Translation of the Alcohol Timeline Followback (TLFB) in 4 Languages

    Nov 1, 2012, 00:00

  • PCV91 The Impact of Atrial Fibrilation Symptoms in the Health Related Quality of Life in Spanish Population (Ulises Study)

    Nov 1, 2012, 00:00

  • PRM33 Real World Eviden Promise and Pitfalls of Real World Data

    Nov 1, 2012, 00:00

  • PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PHP69 Factors May Influence Pattern of Medicine'S Use

    Nov 1, 2012, 00:00

  • PRM71 Differential Time Preference for Money, Life Years and Quality of Life- An Empirical Pilot Study

    Nov 1, 2012, 00:00

  • PRM27 Feasibility, Comparability, and Reliability of the Standard Gamble Compared With the Rating Scale and Time Trade-Off Techniques in the EQ-5D-5L Valuation Study

    Nov 1, 2012, 00:00

  • PDB1 Real-World Incidence of Hypoglycemia and Associated Costs Among Insulin Glargine-Treated Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PRS40 Are Disease Management Programs for COPD Cost-Saving?

    Nov 1, 2012, 00:00

  • PHP24 Assessment of the in Excess NHI-Covered Medications of Outpatients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PCN2 The Relationship of Following Lipid-Lowering Drugs Used With Adjuvant Hormonal Therapy in Breast Cancer Women

    Nov 1, 2012, 00:00

  • PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada- Are There Savings Associated With Device Selection?

    Nov 1, 2012, 00:00

  • PHP13 The Effect of Law for Economical Use of Medications 2006 on the Number of Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PGI12 Assessment of Knowledge, Attitude and Practices of Hepatitis B Patients Towards Their Disease

    Nov 1, 2012, 00:00

  • PDB66 Quantifying the Impact of Poor Glycaemic Control Compared With Guidelines in the Treatment of Type 2 Diabetes in UK Clinical Practice

    Nov 1, 2012, 00:00

  • PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in Singapore

    Nov 1, 2012, 00:00

  • PRM133 Reviewing Translatability Prior to Translation and Linguistic Validation of Pros

    Nov 1, 2012, 00:00

  • PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011

    Nov 1, 2012, 00:00

  • PDB45 Cost-Effectiveness of Vildagliptin Compared to Generic Sulphonylureas Added on to Metformin From the Portuguese Societal Perspective

    Nov 1, 2012, 00:00

  • PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention- A Comparative Effectiveness Study of Clopidogrel and Prasugrel

    Nov 1, 2012, 00:00

  • PSS17 Clinical and Economic Analysis of Linezolid for the Treatment of Methicillin Resistant Staphylococcus Aureus Confirmed Complicated Skin and Soft Tissue Infections Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP14 The Implementation of Essential Medicine Policy in China- Pros and Cons

    Nov 1, 2012, 00:00

  • PRM5 Attribution of Benefit to the Three Disease Dimensions Mortality, Morbidity, Quality of Life Within Early Benefit Assessment (EBA) in Germany

    Nov 1, 2012, 00:00

  • PRM85 Internal Validation of the Syreon Diabetes Model

    Nov 1, 2012, 00:00

  • PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

    Nov 1, 2012, 00:00

  • PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based Survey

    Nov 1, 2012, 00:00

  • PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PRM176 The Value of Further Research- The Added Value of Individual-Level Data

    Nov 1, 2012, 00:00

  • PSS1 Persistence With Statin Therapy and Risk of Psoriasis- A Population-Based Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PHP61 To Evaluate the Effectiveness and Cost of Pharmaceutical Care Volunteer Set Up by Tainan City Government Involved in the Hospital Attached Home Care Patients

    Nov 1, 2012, 00:00

  • PRM104 Examination of Patient Preferen Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany

    Nov 1, 2012, 00:00

  • PCV7 Implementing and Evaluating Pharmacist-Managed Warfarin Service in Inpatient and Outpatient Setting in Taiwan

    Nov 1, 2012, 00:00

  • PND11 Estimating Survival-Benefit of New Therapeutic Interventions in Cystic Fibrosis Patients in Germany, France, UK and Ireland

    Nov 1, 2012, 00:00

  • PSS23 Patient Burden Associated With Lack of Treatment Satisfaction Amongst Psoriasis Patients Receiving Traditional Systemic Therapies

    Nov 1, 2012, 00:00

  • PCV104 Relationship Between Comorbidities, Blood Pressure Control and Therapeutic Schemes in Real-Life Setting Hypertensive Patients

    Nov 1, 2012, 00:00

  • PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data

    Nov 1, 2012, 00:00

  • PCV40 Pharmacotherapy Cost of Patients With Hypertension in Bulgaria

    Nov 1, 2012, 00:00

  • PDB76 Clinical Effectiveness of Increased Physical Activity in Type 2 Diabetes, Systematic Review

    Nov 1, 2012, 00:00

  • PRM121 Burden of Osteoarthritis- Development of a Questionnaire

    Nov 1, 2012, 00:00

  • PCV81 Awareness of Serious Consequences of Non-Compliance and Self-Reported Adherence to Antipaltelet Therapy After Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PMD78 The Switch Study- The Impact of Continuous Glucose Monitoring on Quality of Life and Treatment Satisfaction

    Nov 1, 2012, 00:00

  • PHP66 Socioeconomic Inequalities in Health in Urban Pakistan

    Nov 1, 2012, 00:00

  • PIN25 Health and Economic Benefits of Avoiding Hospital Pen Moves for Dairy Cattle in the United States

    Nov 1, 2012, 00:00

  • PHP100 Prevention or Treatment? Preferences of the Australian Public for Health Technology Assessment Funding Criteria

    Nov 1, 2012, 00:00

  • PCN103 How Much Price Component is Accounted for in State Drugs Purchase Decisions in Ukrainian Oncology?

    Nov 1, 2012, 00:00

  • PSU33 Characteristics and Burden of Tuberous Sclerosis Complex- Results of a Patient and Caregiver Survey in the United States

    Nov 1, 2012, 00:00

  • PCV96 Relationship Between Inflammation and Patient Functioning in Cardiovascular Disease- A Review of the Literature

    Nov 1, 2012, 00:00

  • PSS32 Predictors of Biologic Treatment in Psoriasis Population

    Nov 1, 2012, 00:00

  • PCV3 Prevalence, Associated Comorbidities and Treatment Patterns Among Chronic Kidney Disease Patients- An Analysis Using UK GPRD Data

    Nov 1, 2012, 00:00

  • PHP33 The Use of Extreme Value Statistics in Assessing Long Decision Times in Public Funding of Medicines with New Molecules or Therapeutic Indications

    Nov 1, 2012, 00:00

  • PMS70 Utilization of Pain Medications Among Osteoarthritis Patients Who Initiated Duloxetine and Standard of Care for Pain Management

    Nov 1, 2012, 00:00

  • PSS3 The Efficacy of Epidermal Growth Factor in Burn Wound Treatment

    Nov 1, 2012, 00:00

  • PMH34 Persistence in Use of Antidepressants in Pregnant Women Enrolled in Medicaid in the United States

    Nov 1, 2012, 00:00

  • PMS23 Total Health Care Costs Associated With Ankylosing Spondylitis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PIN10 Epidemiology and Economic Burden of Pneumomococcal Disease in Older Adults in Taiwan

    Nov 1, 2012, 00:00

  • PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PUK12 Cost-Effectiveness of Immunosuppressive Regimens in Renal Transplant Recipients in Germany- A Model Update

    Nov 1, 2012, 00:00

  • PCV22 Pharmacist'S Involvement in a Multidisciplinary Ischemic Stroke Team in and its Associated Cost Avoidance

    Nov 1, 2012, 00:00

  • PHP59 Exploring the Health and Living Standards of Those Who Don't Report Their Migration Status in a Population-Based Survey- The Case of Chile

    Nov 1, 2012, 00:00

  • PHP86 Cost-Effectiveness in Health Care Programs- A Literature Review

    Nov 1, 2012, 00:00

  • PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USA

    Nov 1, 2012, 00:00

  • PIH14 Cost of Illness in Women with Endometriosis

    Nov 1, 2012, 00:00

  • PRM74 Cost Effectiveness of Tirofiban in Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR- Results From a Large, Randomized, Double-Blind Phase III Trial

    Nov 1, 2012, 00:00

  • RU4 Universal Versus Selective Screening for Down'S Syndrome- An Economic Evaluation of Resource Use and Costs by Screening Policy

    Nov 1, 2012, 00:00

  • PA2 Hospital-Based HTA in Italy- Diffusion and Potential Impact

    Nov 1, 2012, 00:00

  • PMH17 Economic Burden in Schizophrenia- A Literature Review

    Nov 1, 2012, 00:00

  • PCN58 Health Economic Impact of Colorectal Cancer

    Nov 1, 2012, 00:00

  • PCV111 Unmet Therapeutic Needs for Patients With Dyslipidemia According to ATP III Guidelines

    Nov 1, 2012, 00:00

  • PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK- A Cost-Utility Analysis

    Nov 1, 2012, 00:00

  • PMH51 Real World Add-on and Switch Patterns for Different Formulation of Methylphenidate

    Nov 1, 2012, 00:00

  • PCV115 Burden of Hypertension in Selected EU Countries- 2010-2025

    Nov 1, 2012, 00:00

  • PSY17 Cost-Utility Analysis of Immune Tolerance Induction (ITI) Therapy Versus On-Demand Treatment With Recombinant FVII (rFVIIa) for Hemophilia A With High Titer Inhibitors in Iran

    Nov 1, 2012, 00:00

  • PHS59 Demographics and Health-State Utilities of Irish Patients With Hepatitis C Infection; Use of the 5-Level EQ-5D Questionnaire

    Nov 1, 2012, 00:00

  • PCN121 Decitabine Reduces Transfusion Dependence in Older Patients With Acute Myeloid Leukaemia- Results From a Post-Hoc Analysis of a Randomised Phase III Trial

    Nov 1, 2012, 00:00

  • PRM138 A Propensity to Get It Right. A Monte Carlo Simulation Study Comparing Statistical Methods to Obtain Correct Cost-Effectiveness Estimates in Observational Studies

    Nov 1, 2012, 00:00

  • PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

    Nov 1, 2012, 00:00

  • PDB79 Treatment Patterns of Oral Anti-Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PCN28 Statin Use and Risk of Breast Cancer- A Meta-Analysis of 24 Observational Studies

    Nov 1, 2012, 00:00

  • PCV80 A Retrospective Study of Comparing Compliance and Persistence of Free Combination Antihypertensive Therapy Versus Single-Pill Combination- Korean Case

    Nov 1, 2012, 00:00

  • PHP170 The Swiss Health Technology Assessment (HTA) Consensus- Guiding Principles

    Nov 1, 2012, 00:00

  • PIH29 Identification of Factors and Their Influence on Patient Adherence to Intravenous Medication for Chronic Conditions- Findings of a Literature Review in Osteoporosis and Crohn's Disease

    Nov 1, 2012, 00:00

  • PMD5 Clinical and Cost-Effectiveness of Third-Generation, Implantable Left Ventricular Assist Devices for People With End-Stage Heart Failure- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP106 Diffusion of Non-Guideline Experience-Based Chemotherapy Care

    Nov 1, 2012, 00:00

  • PCV20 Possible Budget Impact of Internal Reference Pricing for Statins in Turkey

    Nov 1, 2012, 00:00

  • PMS25 Structure of Direct Cost of Care of Patients Treated for Severe Rheumatoid Arthritis in France

    Nov 1, 2012, 00:00

  • PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported Outcomes

    Nov 1, 2012, 00:00

  • PMS18 Importance of COI Studies in the Health Care-Related Decision-Making Process Through the Example of Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PMH22 Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Nov 1, 2012, 00:00

  • PRM158 Placebo-Controlled Clinical Trials- A Difficult Balance “Justification Versus Feasibility” for Academic Sponsors

    Nov 1, 2012, 00:00

  • PHP173 Disentangling the Relationship Between Disability, Socioeconomic Status and Social Capital in Chile- A Population-Based Study

    Nov 1, 2012, 00:00

  • PHP177 Characteristics of Patients Not Consuming Pharmacological Resources Due to a Lack of Drug Prescription During Their Hospital Admission

    Nov 1, 2012, 00:00

  • PHP131 Ensuring That Phase III Programs are Designed to Meet the Evolving HTA Requirements Across the EU5

    Nov 1, 2012, 00:00

  • PCV120 The Factors Which Affect the Price of Antihypertensive Combinations Including Angiotensin Receptor Blockers

    Nov 1, 2012, 00:00

  • PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer Staging

    Nov 1, 2012, 00:00

  • PMS1 Characteristics of Patients With Rheumatoid Arthritis in Turkey- Results from the Turkish League Against Rheumatism RA Registry

    Nov 1, 2012, 00:00

  • PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO Instruments

    Nov 1, 2012, 00:00

  • PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents- Analysis Using the Ramq Database

    Nov 1, 2012, 00:00

  • PCV19 The Burden of Diabetes Mellitus in Belgium- A Retrospective Database Study

    Nov 1, 2012, 00:00

  • PMS14 Impact of Severity Index for Rheumatoid Arthritis on Health Care Costs and Utilizations in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PIH47 Analysis of the Formulary Provision of Children in Ukraine

    Nov 1, 2012, 00:00

  • PCN96 Cost Minimization Analysis of Xeloda® Versus 5-Fluorouracil-Based Treatment for Gastric Cancer Patients in Hong Kong

    Nov 1, 2012, 00:00

  • PHP69 United States Valuation of Child Health Outcomes

    Nov 1, 2012, 00:00

  • PCV117 A Ten Years Longer Life- A Therapeutic Education Program for Hypertensive Patients

    Nov 1, 2012, 00:00

  • PMS22 Indirect Costs Associated With Rheumatoid Arthritis in Turkey

    Nov 1, 2012, 00:00

  • PCV101 Japanese Patients and Physicians Preferences for Anticoagulants Use in Atrial Fibrillation - Results From a Conjoint-Analysis Study

    Nov 1, 2012, 00:00

  • PIN17 Tuberculosis Treatment Outcomes in Four States of Malaysia

    Nov 1, 2012, 00:00

  • ME2 Validation of the Kidney Disease and Quality of Life Questionnaire (KDQOL-36) in Haemodialysis Patients in Singapore

    Nov 1, 2012, 00:00

  • PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical Costs

    Nov 1, 2012, 00:00

  • PRM19 Something for Nothing? The Value of Informal Care

    Nov 1, 2012, 00:00

  • PHP62 Modify Change Order System to Reduce Drug Return Rate in Inpatient Pharmacy

    Nov 1, 2012, 00:00

  • PDB24 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy

    Nov 1, 2012, 00:00

  • PDB71 Patient Access, Hba1C Knowledge, and Health Outcomes Among Type 2 Diabetes Patients in Brazil

    Nov 1, 2012, 00:00

  • PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”)- A Structured Survey Analysis One Year After Enactment

    Nov 1, 2012, 00:00

  • PCN108 Quality of Life and Patient Preferences in Platinum Sensitive Ovarian Cancer

    Nov 1, 2012, 00:00

  • HC1 Price Premium for Innovation? Cost Calculation Method in Japan Versus Cost Utility Analysis in South Korea

    Nov 1, 2012, 00:00

  • PHP46 Trends in Prevalence of Drug Use among Dutch Children from 2005 Until 2010

    Nov 1, 2012, 00:00

  • PIH25 Testosterone Replacement Therapy in Males with Hypogonadism in Sweden- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCN52 English Hospital Costs for Anal Cancer- Preliminary Results from an Investigation Using Hospital Episodes Statistics (HES)

    Nov 1, 2012, 00:00

  • PHP65 Perceptions Among General Medical Practitioners Towards Implementation of Medication Reconciliation Program for Patients Discharged from Hospitals in Penang, Malaysia

    Nov 1, 2012, 00:00

  • PRM3 Turning the Tables to Address the Real Value of Real-World Observational Studies of Novel Anti-Cancer Agents in Multiple Myeloma

    Nov 1, 2012, 00:00

  • PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak Republic

    Nov 1, 2012, 00:00

  • DB3 How a Fear of Hypoglycemia Influences Health-Related Quality of Life in Type 2 Diabetes Mellitus Patients in Spain? Hipoqol-II Study

    Nov 1, 2012, 00:00

  • PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PSU2 The Incidence of Complications After its Thyroidectomy in Patients With Thyroid Cancer in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PCV2 Evaluation of Stroke Risk Associated With Antipsychotic Use in Patinets with Cardiovascular Diseases

    Nov 1, 2012, 00:00

  • PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in China

    Nov 1, 2012, 00:00

  • PCN137 NICE Technology Appraisals and the Uptake of Breast Cancer Drugs in the UK

    Nov 1, 2012, 00:00

  • PHP167 The Role of Decision-Analytic Modeling in German Health Technology Assessments

    Nov 1, 2012, 00:00

  • PND65 Spanish Neurology Therapeutic Society Guidelines for the Treatment of Relapsing Remitting MS- Are They Followed by Spanish Neurologists?

    Nov 1, 2012, 00:00

  • PHS92 Allocation of Research Funding in Health Care in Relation to Disease Burden in Europe

    Nov 1, 2012, 00:00

  • PCN20 Comparative Efficacy and Economic Evaluation of Dacarbazine and Temozolomide in Treatment of Malignant Melanoma in Iran

    Nov 1, 2012, 00:00

  • PCN114 Defining Regulatory Success for Patient-Reported Outcomes (PROs) in Oncology

    Nov 1, 2012, 00:00

  • PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands- a Real-Life Study

    Nov 1, 2012, 00:00

  • PHP77 Health Expenditure and Drug Expenditure - Comparison of Two Western Balkans Countries

    Nov 1, 2012, 00:00

  • CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients

    Nov 1, 2012, 00:00

  • PHP97 The Regional Distribution of Disabled Pensioners of Hungary

    Nov 1, 2012, 00:00

  • PHP34 France Market Access- Review of 2011-2012 Assessments by Transparency Committee

    Nov 1, 2012, 00:00

  • PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong- A Markov Analytic Model

    Nov 1, 2012, 00:00

  • PCN8 Axitinib (AXI) and Best Supportive Care (BSC) in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC)- Results of a Simulated Treatment Comparison (STC) Analyses

    Nov 1, 2012, 00:00

  • PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof

    Nov 1, 2012, 00:00

  • PDB37 Cost-Effectiveness of Adding Twice-Daily Exenatide to Basal Insulin in Patients With Type 2 Diabetes in Scotland

    Nov 1, 2012, 00:00

  • PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in Iran

    Nov 1, 2012, 00:00

  • PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors

    Nov 1, 2012, 00:00

  • PRM19 Using Panel Data to Inform Economic Evaluation

    Nov 1, 2012, 00:00

  • PMD63 A Review of Economic Evaluation Models for Cardiac Resynchronization Therapy With Implantable Cardioverter Defibrillators in Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PRS4 Evidence Synthesis of Association of HLA-B*1502 Allele and Carbamazepine -Induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis- A Systematic Review

    Nov 1, 2012, 00:00

  • PIN84 Trends in Prevalence of Antibacterial Drug Use Among Dutch Children From 2005 Until 2010

    Nov 1, 2012, 00:00

  • PUK4 Total Economic Burden of Both Peritoneal Dialysis and Renal Anemia Treatment

    Nov 1, 2012, 00:00

  • CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?

    Nov 1, 2012, 00:00

  • PMS8 Dupuytren Disease in Italy- A Study Based on a GPs Longitudinal Patient Database

    Nov 1, 2012, 00:00

  • PDB36 Glycemic Control and Quality of Life for Patients With Type 2 Diabetes Mellitus in China

    Nov 1, 2012, 00:00

  • PRM15 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PCN111 The Value of Personalizing Medicine- Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions

    Nov 1, 2012, 00:00

  • PDB13 Interim Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2012, 00:00

  • PHP135 Stakeholders's Views of the Social Insurance Reform in Greece

    Nov 1, 2012, 00:00

  • PND26 Treatment Patterns and Resource Consumption in Patients With Multiple Sclerosis (MS)-Related Spasticity in Germany - Results of Move 1 Study

    Nov 1, 2012, 00:00

  • PSY22 A Cost-Effectiveness Analysis of Parecoxib in the Management of Post-Operative Pain in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PHS49 Cost of Hypoglycaemia in Patients With Diabetes in Poland

    Nov 1, 2012, 00:00

  • PRS27 One-Year Cost-Effectiveness of Montelukast in 2-6-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of Nigeria

    Nov 1, 2012, 00:00

  • PSY18 The Future Characteristics of Bypassing Agents Improving Haemophilia Inhibitor Patients Care From an Economic and Health Related Quality of Life Perspective

    Nov 1, 2012, 00:00

  • QL2 Evaluation of Minimal Clinically Important Differences for Health-Related Quality of Life Scales in Parkinson'S Disease

    Nov 1, 2012, 00:00

  • PRM79 Integrating Patient Preferences and Clinical Trial Data in a Bayesian Model for Quantitative Risk-Benefit Assessment

    Nov 1, 2012, 00:00

  • PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PHP130 Guidelines Without Guidan The Case of Epidemiological Data Beyond Clinical Trials

    Nov 1, 2012, 00:00

  • PMD42 The Incidence of Thyroid Cancer and Medical Cost Among Patients With Thyroid Nodules in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PHP55 Compulsory Licenses for Non-Communicable Diseases- Implications for Pharmaceutical Pricing in Low-Income Countries

    Nov 1, 2012, 00:00

  • PCN14 Evaluation of the Efficacy and Side Effects of Dacarbazine in Comparison to Temozolomide Therapies in Treatment of Malignant Melanoma. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PGI33 Assessing Gas-Related Symptoms and Their Associated Impact on the Daily Life of the General Population and Irritable Bowel Syndrome Patients- International Development of a Questionnaire–Qualitative Steps

    Nov 1, 2012, 00:00

  • PSS24 How Do Glaucoma Patients Assess Different Aspects of Their Treatment- An Elicitation of Patients' Preferences Using the Analytic Hierarchy Process

    Nov 1, 2012, 00:00

  • PRM24 Methods for Analysis of Censored Cost Data

    Nov 1, 2012, 00:00

  • PHP18 Introducing the Western PMA Model in the Middle East- UAE as a Case Study

    Nov 1, 2012, 00:00

  • PCV21 Budget Impact Analysis of Introducing of pCMV-VEGF165 for Treatment of Critical Limb Ischemia From the Russian Health Care System Perspective

    Nov 1, 2012, 00:00

  • PND51 Utility Measurement in Epilepsy- Exploratory Analysis of the Impact of Seizures on Children

    Nov 1, 2012, 00:00

  • PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee Osteoarthritis

    Nov 1, 2012, 00:00

  • PMS2 Alendronate Use and the Risk of Osteonecrosis of Jaw in Taiwan

    Nov 1, 2012, 00:00

  • PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

    Nov 1, 2012, 00:00

  • PRM33 Is There a Labeling Effect in the Valuation of the All-Worst Health State?

    Nov 1, 2012, 00:00

  • PCN42 Cost of Prostate Image-Guided Radiation Therapy- Results from a Randomized Trial

    Nov 1, 2012, 00:00

  • PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

    Nov 1, 2012, 00:00

  • PR3 Utility Values for Chemotherapy-Related Adverse Events- A Review of the Literature

    Nov 1, 2012, 00:00

  • PND39 Cost-Utility Analysis of a Therapeutic Education Program in Parkinson Disease Versus Traditional Care

    Nov 1, 2012, 00:00

  • PRM150 Latent Transition Analysis as a Tool for Analysing Clinical Data

    Nov 1, 2012, 00:00

  • PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in Taiwan

    Nov 1, 2012, 00:00

  • PRM12 Joint Estimation of Progression Free Survival and Overall Survival

    Nov 1, 2012, 00:00

  • PDB75 Association Between Hypoglycaemic Events and Short-Term Disability Among Patients With Diabetes Being Treated With Insulin Using a Claims Database Approach

    Nov 1, 2012, 00:00

  • PRS6 Prevalence of Selected Conditions in Russia Across Sources

    Nov 1, 2012, 00:00

  • PRM3 Standard Cost List for Economic Evaluation in Thailand

    Nov 1, 2012, 00:00

  • PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants Use

    Nov 1, 2012, 00:00

  • PIN9 Contraindications to Hepatitis C Treatment- Which Ones Modify the Likelihood of Veterans Receiving Treatment?

    Nov 1, 2012, 00:00

  • PSY39 Validation of the Lupus Impact Tracker (LIT), a Patient-Reported Outcome (PRO) Tool, in a Prospective Multicenter Longitudinal Study of Systemic Lupus Erythematosus (SLE) Patients

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic Migraine

    Nov 1, 2012, 00:00

  • PRM66 Discrete Event Simulation- Modeling Simultaneous Complications and Outcomes

    Nov 1, 2012, 00:00

  • PHP205 Primary Care Transformation As a Solution to the Epidemic of Chronic Diseases

    Nov 1, 2012, 00:00

  • PMH35 EQ-5D Utilities and Productivity of Adults With Attention-Deficit/Hyperactivity Disorder- Review of the Literature and a Cross-Sectional Survey in Hungary

    Nov 1, 2012, 00:00

  • PDB18 Direct Medical Costs of Diabetes Mellitus in China- Annual Cost of Illness and Long-Term Projections Using a Validated Diabetes Model

    Nov 1, 2012, 00:00

  • PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical Excellence

    Nov 1, 2012, 00:00

  • PSY28 Cost-Effectiveness of Febuxostat in Managing Hyperuricemia in Gout Patients in Spain

    Nov 1, 2012, 00:00

  • PRS43 Budget Impact Analysis of Indacaterol in the Treatment of COPD in a Finnish Hospital District

    Nov 1, 2012, 00:00

  • PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in China

    Nov 1, 2012, 00:00

  • PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PRM103 Estimating Health Related Quality in Type 2 Diabetic Patients Receiving Polytherapy With EQ5D-5L Questionnaire

    Nov 1, 2012, 00:00

  • PCN13 Outcomes and Treatment Patterns of Hepatocellular Carcinoma Patients Stratified by Staging-Guided Treatment Categories in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PHP204 Appropriate Methods for Economic Evaluation of Programmes with Costs and Effects Extending Across Sectors

    Nov 1, 2012, 00:00

  • PRM18 Conducting Pharmaceutical Budget Impact Analyses in Iran- In Accordance With ISPOR Task Force Report on Good Practice for Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PHS7 Prevalence and Cost of Illness of Specific Conditions in a Commercially Insured United States Population

    Nov 1, 2012, 00:00

  • PSY46 Impact of the Neuropathic Pain Component on Quality of Life in Patients With Low Back Pain

    Nov 1, 2012, 00:00

  • PMD2 Hematologic Cancers- Diagnostic Testing Patterns and the Role of Specialty Laboratories in the Age of Personalized Medicine

    Nov 1, 2012, 00:00

  • PHP4 Pharmaceutical Care Intervention for Disease Management in Community Pharmacies in Australia

    Nov 1, 2012, 00:00

  • PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East Libya

    Nov 1, 2012, 00:00

  • PHP181 Costs/QALY Threshold in New Legislation and Its Impact on Access to Innovative Medicines in Slovakia

    Nov 1, 2012, 00:00

  • PMS12 Budget Impact of Golimumab in the Anti-TNF Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

    Nov 1, 2012, 00:00

  • PUK13 Cost-Effectiveness of Ketosteril Treatment in Dialysis Patients

    Nov 1, 2012, 00:00

  • PHP150 Searching for a Threshold in Hungary

    Nov 1, 2012, 00:00

  • PRS7 Patterns of Intranasal Corticosteroid Use Among Individuals Diagnosed With Allergic Rhinitis- Evidence From a Large Claims Database

    Nov 1, 2012, 00:00

  • PMS80 Biologic Therapies for Rheumatoid Arthritis – Eligibility Criteria in the UK

    Nov 1, 2012, 00:00

  • PCV10 Cost-Effectiveness of Extended Duration Thromboprophylaxis After Surgical Discharge

    Nov 1, 2012, 00:00

  • PSS1 Nicotine as a Indicator of Tobacco Exposure and its Effect on Oral Health

    Nov 1, 2012, 00:00

  • PND61 Quality of Life of Spanish Family Carers in Huntington'S Disease

    Nov 1, 2012, 00:00

  • PUK6 Comparison of Quality of Life Between Hemodialysis and Peritoneal Dialysis Patients in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PIN38 Real Life Study of Antifungal Treatment in Greek ICUs- Therapeutic Strategy and Hospital Resource Utilization – Estimator Study

    Nov 1, 2012, 00:00

  • PRM34 The Copyright of Translations of PRO Instruments- The Case of Instruments Used in Lung Diseases

    Nov 1, 2012, 00:00

  • PRM9 Data Requirements for Cost Effectiveness Analysis in Korea and Australia- A Comparison

    Nov 1, 2012, 00:00

  • PMS20 Total Health Care Costs Associated With Rheumatoid Arthritis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PRM97 Translation and Validation of Osteoporosis Knowledge Tool Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PHP93 Development of Biosimilar Mark in EU-5 and USA

    Nov 1, 2012, 00:00

  • PCN99 Cost-Utility of Granulocyte-Colony Stimulating Factors for Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia in Breast Cancer Patients in Belgium

    Nov 1, 2012, 00:00

  • PCN157 Conceptual Framework for the Evaluation of Patient Access Schemes (PAS) in the EU

    Nov 1, 2012, 00:00

  • PCN1 Bisphosphonates and Risk of Osteonecrosis of Jaw in Cancer Patients- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United States

    Nov 1, 2012, 00:00

  • PHP148 Early Benefit Assessment (EBA) in Germany- Differences Between Pharmaceutical Companies' Claims and IQWiG Benefit Assessments

    Nov 1, 2012, 00:00

  • PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study

    Nov 1, 2012, 00:00

  • NI3 Patient Access Schemes in the New NHS

    Nov 1, 2012, 00:00

  • PCV47 Economic Evaluation of Dabigatran for Stroke Prevention Among Patients With Atrial Fibrillation in the Netherlands

    Nov 1, 2012, 00:00

  • PHP93 Does Public Health Spending Matter? Evidence from China Provincial Panel Data

    Nov 1, 2012, 00:00

  • PCV62 Clinical and Economic Analysis of the Effectiveness of Antihypoxia Substance Polydihydroxyphenylenethiosulfonate Sodium (Hypoxenum) in the Complex Angina Pectoris Treatment

    Nov 1, 2012, 00:00

  • PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma- Results of a Real-World Population Based Study

    Nov 1, 2012, 00:00

  • PHP51 Managements of Febrile Neutropenia Among Non-Hodgkin's Lymphoma Patients in Taiwan

    Nov 1, 2012, 00:00

  • PHP10 The Effect of Law for Economical Use of Medications 2006 on the Average Turnover of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PCV15 Bias-Corrected Indirect Comparison Meta-Analysis of New Oral Anticoagulant in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM114 The Challenge of Translating the Picture Naming Subtest of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    Nov 1, 2012, 00:00

  • PMD57 The Costs-Effectiveness of Coban 2 for the Treatment of Venous Leg Ulcers in the Netherlands

    Nov 1, 2012, 00:00

  • PCN119 Patient-Reported Outcomes (PROs) in Antineoplastic Product Approvals in Europe and in the USA

    Nov 1, 2012, 00:00

  • CL1 A Multicriteria Approach for Evaluating Health-Related Quality-of-Life

    Nov 1, 2012, 00:00

  • PCV13 Perceptions of Health During Pregnancy Increase the Risk of Cardiovascular Disease

    Nov 1, 2012, 00:00

  • PDB42 Evaluating the Clinical and Cost Outcomes Associated With Improving Glycemic Control in Type 2 Diabetes Patients in India

    Nov 1, 2012, 00:00

  • PCN109 Quality of Life Assessment of Chronic Myeloid Leukemia Patients in Austria- Cross-Sectional Pilot Study Using the EQ-5D

    Nov 1, 2012, 00:00

  • PHS84 Analyzing Pharmaceutical Expenditure in GreeUnwinding Ariadne's Clue

    Nov 1, 2012, 00:00

  • PSS9 Cost of Blindness and Visual Impairment in Slovakia

    Nov 1, 2012, 00:00

  • PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia

    Nov 1, 2012, 00:00

  • PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of Srpska

    Nov 1, 2012, 00:00

  • PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study

    Nov 1, 2012, 00:00

  • PDB33 Burden of Disease Attributable to Clinical and Subclinical Hypothyroidism in the Spanish Population

    Nov 1, 2012, 00:00

  • PSS2 Epidemiology, Treatment Patterns and Medical Expenses of Diabetic Macular Edema in Taiwan- A Nationwide Claim-Based Database Study

    Nov 1, 2012, 00:00

  • PSY3 Assessing the Cost Effectiveness of Public Health Interventions to Prevent Obesity- A Systematic Review of the Effectiveness of 16 Obesity Prevention Interventions

    Nov 1, 2012, 00:00

  • PIH28 The Project Sincope in Triveneto (PROSIT) Study. A Multicenter Study Regarding Syncope Management in an Italian Region

    Nov 1, 2012, 00:00

  • PCV15 A Cost-Effectiveness Analysis Between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention Among Hypertension Patients in China

    Nov 1, 2012, 00:00

  • PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid Programs

    Nov 1, 2012, 00:00

  • PGI14 Characteristics of Diverticulitis-Related Emergency Department Visits in the United States

    Nov 1, 2012, 00:00

  • PCN134 Expenditures and Availability of Orphan Drugs in the Czech Republic- Seven Year Experience (2004 – 2010)

    Nov 1, 2012, 00:00

  • PHP128 Amnog in Year 2- Insights from Early Benefit Assessments in Germany

    Nov 1, 2012, 00:00

  • PMS13 Comparative Budget Impact of Teriparatide Versus Parathormone 1-84 Using Indirect Comparison Efficacy Data in Italy

    Nov 1, 2012, 00:00

  • RU1 Cholinesterase Inhibitors- A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S Dementia

    Nov 1, 2012, 00:00

  • PCN31 Treatments Pattern and Outcomes of Ovarian Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PRM111 Pediatric Patient-Reported Outcomes Assessment- A Case Study in Epidermolysis Bullosa

    Nov 1, 2012, 00:00

  • PHS9 Regional and Age Distribution Evaluation of the Outpatient Care Physiotherapy Services for High Incidence Traumatic Injuries

    Nov 1, 2012, 00:00

  • PRM125 Whose Values in Health? A Comparison of Adult and Adolescent Values for the CHU9D and AQOL-6D

    Nov 1, 2012, 00:00

  • PSY12 The Prevalence and Treatment Status of Hemophilia in India, Russia, Taiwan and Turkey- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PND1 12-Month Clinical Evolution of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PDB4 Development and Validation of RP-HPLC-UV Method for Determination of Glipizide in Human Plasma

    Nov 1, 2012, 00:00

  • PSY36 Changes in Pain Intensity and Health Related Quality of Life (QoL) in Patients With Peripheral Neuropathic Pain After a Single Treatment of 8% Capsaicin Patch – Results From a Swedish 12 Week Prospective Observational Study

    Nov 1, 2012, 00:00

  • PIN34 Development of Treatment Costs of Patients Undergoing Remission Induction Chemotherapy- A Historical Comparison Before and After Introduction of Posaconazole Prophylaxis

    Nov 1, 2012, 00:00

  • PMH6 Factors Associated with Medical Expenditure for Dementia in South Korea

    Nov 1, 2012, 00:00

  • PMD90 Renal Denervation for Resistant Hypertension- HTA Report of the Veneto Region

    Nov 1, 2012, 00:00

  • PMH41 A Change of Dysuria, Xerostomia, Anxiety and Depression After Initiation of Inhaled Drugs

    Nov 1, 2012, 00:00

  • PHP87 Evaluation of Real Life Use of Sugammadex for Decurarization of Neuromuscular Blockade in Surgical Interventions in Belgium

    Nov 1, 2012, 00:00

  • DB4 Screening for Diabetic Retinopathy in Hong Kong- Is Inverse Care Law Operating?

    Nov 1, 2012, 00:00

  • PSY23 Pharmacoeconomic Aspects of Dexketoprofen Trometamol and Diclofenac in Acute Post-Traumatic Pain

    Nov 1, 2012, 00:00

  • DB2 Vitamin D Deficiency and Diabetes- Perceptions of Pharmacists and Physicians

    Nov 1, 2012, 00:00

  • PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With Diabetes

    Nov 1, 2012, 00:00

  • PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis from a Brazilian Private Perspective

    Nov 1, 2012, 00:00

  • PHS80 Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2012, 00:00

  • PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PSY32 Measuring the Level Impact of Neuropathic Pain in the EU

    Nov 1, 2012, 00:00

  • PDB24 Cost Analysis of Adding Pregabalin or Gabapentin to Usual Care in the Management of Community-Treated Patients With Painful Diabetes Peripheral Neuropathy in Spain

    Nov 1, 2012, 00:00

  • PHP44 Implementation Evaluation of Essential Medicines List 2011 in a Rural Resource Limited District Hospital in India

    Nov 1, 2012, 00:00

  • PND13 Old and New Antiepileptic Drugs Utilization in Iran

    Nov 1, 2012, 00:00

  • PCV28 2-Year Incidence of Stroke and Hemorrhages Hospitalizations and Costs Within Atrial Fibrillation Patients in France

    Nov 1, 2012, 00:00

  • PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific Countries

    Nov 1, 2012, 00:00

  • PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain

    Nov 1, 2012, 00:00

  • PRS15 The Economic Impact of COPD in Patients of Working Age- Results From ‘COPD Uncovered' the Netherlands

    Nov 1, 2012, 00:00

  • PMD1 Economic Value of Screening for Early Parkinson's Disease in a European Setting

    Nov 1, 2012, 00:00

  • PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • PHS27 Evaluation of the Clinical and Economic Burden of the Human Immunodeficiency Virus in United States Veteran Patients

    Nov 1, 2012, 00:00

  • PRM151 Collapsibility and Censoring- What's the Bias in Estimated Survival Time?

    Nov 1, 2012, 00:00

  • PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PHP122 The Use of Quantitative and Qualitative Criteria for Making Drug Funding Decisions

    Nov 1, 2012, 00:00

  • PRM6 Transferability of Indirect Cost of Chronic Disease- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP120 New Pricing Dynamics in Big Five EU- Case Study of Biosimilar GM-CSF Products

    Nov 1, 2012, 00:00

  • PCN116 Mapping FACT-P to EQ-5D in a Large Cross-Sectional Study of Metastatic Castrate-Resistant Prostate Cancer Patients

    Nov 1, 2012, 00:00

  • PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic Tests

    Nov 1, 2012, 00:00

  • PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France

    Nov 1, 2012, 00:00

  • PIN67 Cost Minimization Comparison of a Vaccination With Campaign Program for Corporations Using PCV13 Vesus Free PCV10 With Paid Campaign

    Nov 1, 2012, 00:00

  • PND14 Characteristics of Multiple Sclerosis Patients With High Relapse Rate Using a Claims Database

    Nov 1, 2012, 00:00

  • PCV95 The Patient's Experience of Nuisance Bleeding and Bruising While on Antiplatelet Medications for ACS

    Nov 1, 2012, 00:00

  • PHS40 An Example of Irrational Decision Making in the Elderly- Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?

    Nov 1, 2012, 00:00

  • PSS16 Cost-Effectiveness of Tacrolimus Ointment in Children With Moderate and Severe Atopic Dermatitis- Twice-Daily Maintenance Treatment Versus Standard Twice-Daily Reactive Treatment of Exacerbations From the Perspective of the Spanish Na ...

    Nov 1, 2012, 00:00

  • PSS6 Health Economic Evaluation of Preservative-Free Tafluprost Versus Preserved Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension (OH)

    Nov 1, 2012, 00:00

  • PCV45 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndromes From a Turkish Health Care Perspective Based on Data From the Plato Trial

    Nov 1, 2012, 00:00

  • PHP115 Geographical Distribution of Pharmacies Versus Population- The Case of Two Capital Cities in Iran

    Nov 1, 2012, 00:00

  • PCV61 Pharmacoeconomic Evaluation of Olmesartan, Losartan and Valsartan in Treatment of Essential Arterial Hypertension

    Nov 1, 2012, 00:00

  • PRM62 Time-Dependency for Treatment Sequences- A Case-Example in Epilepsy

    Nov 1, 2012, 00:00

  • PCV123 VIP Study- Venous Thromboembolism Prophylaxis Patterns and Drug Use in Patients Undergoing Total Knee and Hip Arthroplasty in Brazil

    Nov 1, 2012, 00:00

  • PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

    Nov 1, 2012, 00:00

  • PHP45 Impact of Generics Policy on the Generic Penetration

    Nov 1, 2012, 00:00

  • PMD64 Can Molecular Allergology Improve Allergen-Specific Immunotherapy Adherence and Patient Quality of Life in a Complex Pollen Area?

    Nov 1, 2012, 00:00

  • PRM37 Indirect Identification of Payer Perceptions Through Retrospective Analysis of Interview Write-Ups

    Nov 1, 2012, 00:00

  • PMD75 Does Presenting Follow-Up Test Information Affect People's Preferences for Colorectal Cancer Screening Tests? A Discrete Choice Experiment

    Nov 1, 2012, 00:00

  • PRM148 Sample Size and Power Considerations in Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments- A UK Perspective

    Nov 1, 2012, 00:00

  • PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

    Nov 1, 2012, 00:00

  • PHP92 Stakeholders's Views on Recently Introduced Measures to Promote Generics Consumption in Greece

    Nov 1, 2012, 00:00

  • PRM28 Assessing the Completeness of Maternity Data Recording in UK Primary and Secondary Care

    Nov 1, 2012, 00:00

  • PCV103 Development of a New Questionnaire to Measure Satisfaction With Medical Care in Patients With Atrial Fibrillation (Safuca)

    Nov 1, 2012, 00:00

  • PRM25 First Drive-Through Pharmacy Service in Taiwan

    Nov 1, 2012, 00:00

  • PDB65 Impairment of Work Productivity and Daily Activities in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PND36 Cost-Effectiveness of Different Interferon-Beta Therapies for Relapsing-Remitting and Secondary Progressive Multiple Sclerosis- A Markov Model Based on Long-Term Clinical Data

    Nov 1, 2012, 00:00

  • PRM72 Model Selection Process for Cost Effectiveness Analysis of an Organized AAA Screening in Austria

    Nov 1, 2012, 00:00

  • PHP176 Socioeconomic Inequalities Concerning the Self-Rated Health Status in Gree A Comparative Analysis of Post-Crisis Effects

    Nov 1, 2012, 00:00

  • PHP2 Evaluation and Comparison of Pharmacovigilance Systems in 70 Different Countries for Consumer Reporting of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PSY21 The Disease Burden Among Patients With Psoriasis in China

    Nov 1, 2012, 00:00

  • PGI8 Cost Effectiveness Analysis of Antibiotics Used in Gastrointestinal Surgeries

    Nov 1, 2012, 00:00

  • PCN105 Impact of Pharmacy Channel on Abandonment Rate of Oral Oncolytics

    Nov 1, 2012, 00:00

  • PRM110 Planning and Executing Qualitative Research With Adolescents in an Orphan Disease

    Nov 1, 2012, 00:00

  • PDB72 Main Factors Associated to Costs of Type 2 Diabetes Mellitus (DM2) Care in Spain. A Systematic Review of the 2001-2011 Literature

    Nov 1, 2012, 00:00

  • PIN26 Real Life Effectiveness of Antibiotics

    Nov 1, 2012, 00:00

  • RE1 Factors Influencing Drug Reimbursement Decision in Scotland

    Nov 1, 2012, 00:00

  • PCN91 The Cost-Effectiveness of Trastuzumab Over the Product Life Cycle in Portugal- A Dynamic and Societal Perspective

    Nov 1, 2012, 00:00

  • PGI4 Evaluation of the Efficacy and Incontinence Rate of Biomaterials in Comparison to Conservative and Other Interventional Therapies in Treatment of Perianal Fistula. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV105 The Importance of a Definition- Cost Implications for the UK of Alternative Definitions of Hypercholesterolaemia

    Nov 1, 2012, 00:00

  • PHS53 Use of Health Care Administrative Databases to Estimate the Burden of Multiple Sclerosis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada

    Nov 1, 2012, 00:00

  • CV4 Association Between Knowledge and Health Related Quality of Life? Is Patient Education Always Beneficial?

    Nov 1, 2012, 00:00

  • PRM117 Exploring Patient Perceptions of, and Preferences for, Pain Response Scales

    Nov 1, 2012, 00:00

  • PIH9 Compare Health Care Utilization and Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Nov 1, 2012, 00:00

  • PCV49 Economic Evaluation of Rivaroxaban in Stroke Prevention Among Patients With Atrial Fibrillation in Greece

    Nov 1, 2012, 00:00

  • PGI2 Gastroprotective Evaluation of Phyllanthus Emblica in the Patients With Gastric Ulcers

    Nov 1, 2012, 00:00

  • PUK25 Patterns of Treatment Failure Among Patients Receiving Anticholinergics for Overactive Bladder (OAB) Treated in a Managed Care Setting

    Nov 1, 2012, 00:00

  • PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System

    Nov 1, 2012, 00:00

  • PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting Injectable

    Nov 1, 2012, 00:00

  • PMH29 Cost Effectiveness of Quetiapine Extended Release Compared With Quetiapine Immediate Release in Schizophrenic Patients in Mexico

    Nov 1, 2012, 00:00

  • PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PND54 Fatigue and Quality-of-Life in Multiple Sclerosis Patients With Spasticity in Germany - Results of the Move 1 Study

    Nov 1, 2012, 00:00

  • PMS55 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporotic Men in Hungary

    Nov 1, 2012, 00:00

  • PHP35 Systematic Review of Key Issues in Endoscope Reprocessing – Guideline Adherence, Health Outcomes and Resource Use

    Nov 1, 2012, 00:00

  • PHP67 Cost Analysis of Home-Based Medication Reviews in a Multi-Ethnic Asian Population- A Pilot Study

    Nov 1, 2012, 00:00

  • PMS20 Patients Reported Outcomes in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated With Golimumab- Sub-Analysis of Asia Population Enrolled in Multicentre Phase Iii Clinical Trials

    Nov 1, 2012, 00:00

  • PHP73 Using Decision Analysis Method to Evaluate the Effectiveness of Similar Function Medical Materials in Hospital

    Nov 1, 2012, 00:00

  • PIH8 Comparative Pharmacoeconomic Study of Disposable and Reusable Gowns and Drapes

    Nov 1, 2012, 00:00

  • PCN4 Decision-Analytic Model for the First-Line Therapy of Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the U ...

    Nov 1, 2012, 00:00

  • PHP12 The Evaluation of Vaccine Refrigerator Temperature Survey Conducted by Primary Care Units of Songkhla Hospital

    Nov 1, 2012, 00:00

  • PGI12 Cost of Disease Related Malnutrition in Croatia – a Hidden Cost in the Health Care Closet Wants out

    Nov 1, 2012, 00:00

  • PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

    Nov 1, 2012, 00:00

  • PRM166 The Challenge of Assessing Health Technologies Early in the Development. Systematic Literature Review of Methods in Use

    Nov 1, 2012, 00:00

  • PSY5 Estimating the Prevalence of Fibromyalgia and Its Impacts on Health in Thais- A Community-Survey in Bangkok, Thailand

    Nov 1, 2012, 00:00

  • PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With Osteoarthritis

    Nov 1, 2012, 00:00

  • PHP154 A Study Comparing the Different Proceeses for Patient Input in Six Different European HTA Systems

    Nov 1, 2012, 00:00

  • PRM20 Construction of the Markov Model for Hepatitis B Virus Related Diseases in Japan

    Nov 1, 2012, 00:00

  • EX1 The Effects of Polypharmacy on Health Care Costs and Hospital Admissions in Thai Elderly Population- Multivariate Two-Part Models

    Nov 1, 2012, 00:00

  • PSY3 Disease Activity Indices (DAIS) in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PCV26 Cost Analysis of Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome in Russia

    Nov 1, 2012, 00:00

  • PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in China

    Nov 1, 2012, 00:00

  • PND8 Prevalence and Incidence Rates of Multiple Sclerosis in the United States

    Nov 1, 2012, 00:00

  • PDB17 Systematic Review of Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in Bangladesh, India and Pakistan

    Nov 1, 2012, 00:00

  • PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in Indonesia

    Nov 1, 2012, 00:00

  • PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIH11 A Survey Evaluating General Public Perceptions Towards Traditional Medicines Used for Aphrodisiac Purpose

    Nov 1, 2012, 00:00

  • PHP60 Iranian Pharmacists' Job Satisfaction- Analysis Through Various Job Characteristics

    Nov 1, 2012, 00:00

  • PHP108 Early Access Programmes (EAPs)- Review of Non- European System

    Nov 1, 2012, 00:00

  • PIH46 Outcomes of Drug Use During Pregnancy- A Novel Database in the Netherlands to Study Drugs Risk on the Yet Unborn

    Nov 1, 2012, 00:00

  • PRM112 Recruitment Costs and Efficiency Varies With Condition/ Patient Population

    Nov 1, 2012, 00:00

  • PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in Taiwan

    Nov 1, 2012, 00:00

  • CE2 Cost-Effectiveness of the Real-World Use of Nucleic Acid Test Screening to Donated Blood for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus- Experience From Taiwan, a Country With a High Prevalence of Hepatitis B and C Infec ...

    Nov 1, 2012, 00:00

  • PND19 Pharmacological Costs of Recurrent-Remitent Multiple Sclerosis Treatment in Spain

    Nov 1, 2012, 00:00

  • PND69 Development and Validation of a Patient-Reported Outcomes Questionnaire for the Assessment of Hereditary Angioedema in Observational Studies

    Nov 1, 2012, 00:00

  • PHP47 Dose Dependent Evaluation of Intestinal P-GP Activity After One Week Oral Administration of Bacopa Monniera

    Nov 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127 (current)
  • 128
  • 129
  • 130
  • »